Pre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumab

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

NCT07020819 ·Status: RECRUITING ·Phase: PHASE3

A Study of Galcanezumab in Healthy Participants.

NCT02836613 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3016859 in Healthy Volunteers

NCT01545583 ·Status: COMPLETED ·Phase: PHASE1

Daratumumab for Polyneuropathy Associated With MGUS

NCT06046287 ·Status: WITHDRAWN ·Phase: PHASE2

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

NCT07122648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Galcanezumab in Healthy Participants

NCT02576951 ·Status: COMPLETED ·Phase: PHASE1

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

NCT07284420 ·Status: RECRUITING ·Phase: PHASE2

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

NCT05986162 ·Status: UNKNOWN ·Phase: PHASE1

Natalizumab in Inclusion Body Myositis (IBM)

NCT02483845 ·Status: UNKNOWN ·Phase: PHASE1

TARGET Post-Approval Study

NCT02800863 ·Status: COMPLETED

A Study of LY3079514 in Healthy Participants

NCT02242903 ·Status: COMPLETED ·Phase: PHASE1

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

NCT04295538 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY4060874 in Healthy Participants

NCT06709820 ·Status: COMPLETED ·Phase: PHASE1

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

NCT05248659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

NCT04163419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

NCT05895786 ·Status: RECRUITING ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

NCT01086540 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY4088044 in Healthy Participants

NCT07090785 ·Status: RECRUITING ·Phase: PHASE1

TNFα Monoclonal Antibody for Acute Spinal Cord Injury

NCT04988425 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease

NCT04432298 ·Status: TERMINATED ·Phase: PHASE2

A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body

NCT03241264 ·Status: COMPLETED ·Phase: PHASE1

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

NCT03864185 ·Status: COMPLETED ·Phase: PHASE2

Immunotherapy and Paraneoplastic Neurological Syndromes

NCT02343211 ·Status: COMPLETED ·Phase: PHASE2

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

NCT04976140 ·Status: COMPLETED ·Phase: PHASE1/PHASE2